- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Lymphoma, Large B-Cell, Diffuse in Ireland
Total 203 results
-
AmgenTerminatedRelapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaUnited States, France, Italy, Belgium, Canada, Mexico, Germany, Korea, Republic of, United Kingdom, Taiwan, Australia, Spain, Austria, Israel, Czechia, Greece, Russian Federation, Poland, Turkey, Bulgaria, Ireland
-
University Hospital MuensterDeutsche Krebshilfe e.V., Bonn (Germany)RecruitingLymphoblastic Lymphoma, ChildhoodSpain, Austria, Denmark, Finland, Germany, Belgium, Switzerland, China, Czechia, France, Hungary, Ireland, Israel, Italy, Netherlands, Norway, Poland, Portugal, Russian Federation, Slovakia, Sweden
-
TG Therapeutics, Inc.CompletedChronic Lymphocytic LeukemiaUnited States, Israel
-
Dutch Childhood Oncology GroupCompletedLeukemiaUnited States, United Kingdom, Belgium, Italy, Germany, Austria, Ireland, Netherlands, France, Sweden, Czech Republic
-
Hoffmann-La RocheCompletedChronic Lymphocytic LeukemiaItaly, Sweden, Belgium, Brazil, Canada, Germany, Ireland, Korea, Republic of, Spain, Russian Federation, France, Finland, Israel, Estonia, Romania, Egypt, Thailand, Switzerland, Bosnia and Herzegovina, Slovakia, Turkey, Lithuania, P... and more
-
Rigshospitalet, DenmarkNordic Society for Pediatric Hematology and OncologyCompletedAcute Lymphoblastic LeukemiaFinland, Denmark, Iceland, Norway, Sweden
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLymphomaUnited States, Canada, Australia, Switzerland, Puerto Rico
-
CelgeneCompletedChronic Lymphocytic LeukemiaUnited States
-
Spectrum Pharmaceuticals, IncOnxeoCompletedPeripheral T-cell LymphomaUnited States, Belgium, United Kingdom, Germany, Spain, Poland, Israel, Netherlands, Canada, Croatia, Denmark, France, Hungary, Italy, Russian Federation, Slovakia, South Africa
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)TerminatedLeukemiaUnited States, Canada
-
Novartis PharmaceuticalsTerminatedLeukaemia, Lymphocytic, ChronicSpain, United States, Belgium, India, United Kingdom, Netherlands, Czechia, Germany, Greece, Italy, Russian Federation, Sweden, Canada, Ireland, Poland, France, Brazil
-
BeiGeneRecruitingMantle Cell Lymphoma | Relapsed Mantle Cell Lymphoma | Refractory Mantle Cell Lymphoma (MCL)United States, China, Israel, Belgium, Poland, Spain, Turkey, Brazil, Italy, Canada, United Kingdom, France, Germany, Argentina, Puerto Rico
-
University of AarhusCompletedRecurrence | Precursor Cell Lymphoblastic Leukemia-LymphomaFinland, Denmark, Iceland, Norway, Sweden
-
National Cancer Institute (NCI)Active, not recruitingRecurrent B Acute Lymphoblastic LeukemiaUnited States, Canada, Puerto Rico, Australia, New Zealand
-
Children's Oncology GroupNational Cancer Institute (NCI); EsPhALL Network/ BFM Study GroupRecruitingAcute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia | T Acute Lymphoblastic Leukemia | Mixed Phenotype Acute LeukemiaUnited States, Canada, Puerto Rico, Australia, Finland, New Zealand, Saudi Arabia, Germany, Austria, Belgium, Chile, Czechia, France, Italy, Netherlands, Sweden, Switzerland, Hong Kong, Israel
-
National Cancer Institute (NCI)CompletedAcute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1United States, Canada, Australia, New Zealand, Puerto Rico
-
TG Therapeutics, Inc.TerminatedChronic Lymphocytic LeukemiaUnited States, Poland, Italy, United Kingdom
-
Merck Sharp & Dohme LLCRecruitingNon-Hodgkins Lymphoma | Hematologic Malignancies | Chronic Lymphocytic Leukaemia | Waldenstroms MacroglobulinaemiaPoland, United States, Argentina, Australia, Brazil, Canada, France, Israel, Italy, Spain, Switzerland, Turkey, United Kingdom, Korea, Republic of, Germany, Denmark, China, Romania, Czechia, Hungary, Ireland, Ukraine
-
German CLL Study GroupAbbVie; Hoffmann-La Roche; Swiss Group for Clinical Cancer Research; Stichting... and other collaboratorsCompletedChronic Lymphocytic LeukemiaIreland, Germany, Israel, Austria, Belgium, Denmark, Switzerland, Finland, Sweden, Netherlands
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedMantle Cell LymphomaFrance, Poland, United Kingdom, Belgium, Germany, Taiwan, Spain, Colombia, Portugal, Ukraine, Canada, Netherlands, Sweden, Korea, Republic of, Chile, Brazil, Russian Federation, Hungary, Ireland, Mexico, Czechia
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingMantle Cell Lymphoma | Liver LymphomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLymphomaUnited States, Puerto Rico
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); Cancer and Leukemia Group B; SWOG Cancer Research...CompletedLeukemiaUnited States, Canada, Puerto Rico, South Africa
-
CelgeneCompletedMantle Cell LymphomaUnited States, France, Belgium, Austria, Israel, Singapore, Spain, United Kingdom, Hungary, Colombia, Germany, Italy, Turkey, Puerto Rico
-
TG Therapeutics, Inc.TerminatedChronic Lymphocytic LeukemiaUnited States, Israel, Italy, Poland, Russian Federation, Spain, United Kingdom
-
CelgeneActive, not recruitingLymphoma, Non-HodgkinUnited States, Germany, Puerto Rico
-
Janssen Research & Development, LLCPharmacyclics LLC.Active, not recruitingMantle Cell LymphomaUnited States, France, Poland, United Kingdom, China, Belgium, Germany, Taiwan, Spain, Argentina, Israel, Turkey, Ukraine, Japan, Canada, Greece, Korea, Republic of, Netherlands, Brazil, Russian Federation, Puerto Rico, Australia, I... and more
-
Dana-Farber Cancer InstituteServierActive, not recruitingAcute Lymphoblastic Leukemia, PediatricUnited States, Canada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Recruiting
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLymphoma | Graft Versus Host DiseaseUnited States
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingLymphoma, Mantle-CellUnited States, China, Spain, Belgium, Canada, Australia, Czechia, Italy, Taiwan, Germany, Japan, New Zealand, United Kingdom, Denmark, Brazil, Israel, France, Netherlands, Korea, Republic of, Poland, Hungary, Austria, Switzerland, Por... and more
-
Mats HeymanNordic Society for Pediatric Hematology and Oncology; NordForsk; The Swedish...RecruitingLeukemia, Acute LymphoblasticEstonia, Spain, Finland, Denmark, Iceland, Lithuania, Norway, Sweden
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedB-cell Childhood Acute Lymphoblastic Leukemia | L1 Childhood Acute Lymphoblastic Leukemia | L2 Childhood Acute Lymphoblastic Leukemia | Intermediate Risk Recurrent Childhood Acute Lymphoblastic LeukemiaUnited States, Canada, Australia, Switzerland
-
Fred Hutchinson Cancer CenterGlobal Life Technologies Corp.SuspendedHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Solid NeoplasmUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingRefractory T Acute Lymphoblastic Leukemia | Recurrent T Acute Lymphoblastic LeukemiaUnited States
-
Mats HeymanAssistance Publique - Hôpitaux de Paris; Karolinska Institutet; Pfizer; The Swedish... and other collaboratorsRecruitingLeukemia, Acute LymphoblasticBelgium, United Kingdom, Denmark, Germany, Portugal, Netherlands, Estonia, France, Finland, Iceland, Norway, Sweden, Lithuania, Ireland
-
National Cancer Institute (NCI)Active, not recruitingB Acute Lymphoblastic Leukemia | Acute Leukemia of Ambiguous Lineage | Mixed Phenotype Acute LeukemiaUnited States, Canada, Puerto Rico, Australia
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingAcute Lymphoblastic Leukemia | Acute Undifferentiated Leukemia | Childhood T Acute Lymphoblastic LeukemiaUnited States, Canada, Australia, New Zealand
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLeukemiaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingOsteosarcoma | Lymphoblastic Lymphoma | Recurrent Lymphoma | Recurrent Malignant Neoplasm | Hodgkin Lymphoma in Remission | Leukemia in Remission | Recurrent LeukemiaUnited States, Australia, Canada, Puerto Rico
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Adult Acute Lymphoblastic Leukemia | Recurrent Adult Non-Hodgkin Lymphoma | Recurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood Non-Hodgkin LymphomaUnited States, Canada, Puerto Rico, Australia, Switzerland
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingMantle Cell Lymphoma | CD20 PositiveUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedAcute Lymphoblastic LeukemiaUnited States, Canada, Puerto Rico, Australia, New Zealand, Switzerland, Ireland
-
Princess Maxima Center for Pediatric OncologyUniversity of Milano Bicocca; Amgen Europe B.VRecruitingAcute Lymphoblastic Leukemia | Mixed Phenotype Acute LeukemiaNorway, Finland, Denmark, Netherlands, Hungary, Argentina, Australia, Austria, Belgium, Czechia, France, Germany, Ireland, Italy, Japan, Portugal, Saudi Arabia, Sweden
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Canada, Australia, Switzerland, Puerto Rico, Netherlands
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Canada, Australia, Switzerland, Puerto Rico, Netherlands
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Canada, Australia, Switzerland, New Zealand
-
Incyte CorporationChildren's Oncology GroupActive, not recruitingLeukemiaUnited States, Canada, Puerto Rico
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Active, not recruitingLymphoma | Neurotoxicity | Therapy-related ToxicityUnited States, Canada
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedLeukemia | Drug/Agent Toxicity by Tissue/OrganUnited States, Canada